The Incidence of Diabetes Unawareness in Patients Hospitalized Outside Internal Medicine Services and Related Factors

Diabetes Clinical Trial

Official title:

The Incidence of Diabetes Unawareness in Patients Hospitalized Outside Internal Medicine Services and Related Factors: A Multidisciplinary Study for Detecting Undiagnosed Diabetes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04694326
• Other study ID #: INPATIENTA1C
• Status: Completed
• Start date: April 20, 2017
• Est. completion date: December 31, 2017

Study information

• Verified date: January 2021
• Source: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Our purpose is to determine the prevalence of undiagnosed diabetes by checking HbA1c in patients hospitalized outside internal medicine services and assess whether or not there is a difference between those without diabetes awareness and those with known diabetes in terms of age, sex, education status, presence of comorbidity and Body Mass Index (BMI).

Description:

The study included 630 patients hospitalized outside internal medicine services and internal medicine side-branch services at or over the age of 18 whose anthropometric measurements could be made. The sociodemographic properties and comorbidities of the patients were recorded. Their anthropometric measurements, fasting blood glucose and HbA1c measurements were made. Those with a previous diagnosis of diabetes were grouped as 'Known Diabetes', those without a known diabetes diagnosis but with an HbA1c value of ≥6.5% during hospitalization were grouped as 'Diabetes Unaware', and those with an HbA1C value of <6.5% were grouped as 'No Diabetes'. Whether or not there were differences among the 3 groups based on sociodemographic characteristics, anthropometric measurements and disease statuses was examined.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 630
• Est. completion date: December 31, 2017
• Est. primary completion date: December 31, 2017
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Inpatients of units other than internal medicine services and internal medicine side-branch services at or

• Over the age of 18

• Anthropometric measurements could be made were included

Exclusion Criteria:

• Had comorbidities that could affect their anthropometric measurements (heart failure, edema, liver cirrhosis, cancer, cachexia, Cushing syndrome, etc.),

• Who had been using steroids for more than a month,

• Pregnant

• Postoperative period

Related Conditions & MeSH terms

• Diabetes
• Diabetes Mellitus
• Hba1c
• Inpatient Facililty Diagnoses
• Unconsciousness

Intervention

Diagnostic Test:
• HbA1c
The participants' age, sex, education level, known diseases, unit of hospitalization and inpatient diagnosis were questioned and recorded. Height, weight and waist circumference measurements were taken. Fasting blood sugar and HbA1c measurements were made

Locations

Country	Name	City	State
Turkey	Sultan Abdülhamid Han Training and Research Hospital	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Diabetes Unawaraness Prevalance	Diabetes unawaraness prevalance in inpatient settings	14 days